Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7396 p442
15 April 2006

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Letters

· PSNC
· Antibiotics
· Packaging
· Medicines use reviews
· Smoking cessation
· Statistics
· Statins
· Drug misuse
· Agenda for Change
· Palliative care
· The Society (2)


Letters to the Editor

Palliative care

Pharmacists can be an asset to a local hospice

From Mr N. Baumber, FRPharmS

I was pleased to see palliative care in the community being highlighted by Clare Amass in her excellent introduction to the Gold Standards Framework (PJ, 25 March, p353 PDF (50K)).

Community pharmacists can, and do, offer a lot of support to their own patients who are suffering from incurable illnesses and they can also be an asset to their local hospice. My own involvement has been with a hospice charity providing general and supportive palliative care. Our policy has been to accept patient self-referral and referral from carers and families, and not just to wait for medical referrals. Even so, I find that referrals to hospice care are coming later and later and therefore missing the opportunity for anyone to help except in extremis.

This may be a local failure in communication but part of the problem is also the tendency for the Government to narrow the definition of palliative care to the last few weeks of life in order to reduce the budget. For someone who is diagnosed with breast cancer, who is at first traumatised, then treated and eventually deemed cured, the process can take up to six years not six weeks. The public perception of a hospice may be as unhelpful to the people who need it as the stereotype of dispensing is when it is misrepresented as the counting of tablets from one box to another.

Specialist care is an essential pinnacle of hospice care but it is applicable to a relatively small number of patients. The whole point of the hospice movement, however, is that support and facilities should be made available from the earliest moment after diagnosis so that the patient and family can benefit from the many agencies that are available to help. Respite beds, day care, hospice at-home services, bereavement counselling and voluntary help can make a world of difference at the right moment if a rapport has been established and the psychological barriers removed by an early introduction.

Depending on what is available in your locality, community pharmacies could become an ideal location for introductory information, leaflets, displays and even referral to hospice services if the patient so wishes. I hope pharmacists will be moved to broaden their knowledge of local hospice and palliative care services, become involved in fund-raising or even offer their services as trustees. Their help will always be welcomed and much appreciated, especially if that interaction results in earlier referrals.

Noel Baumber
Grantham, Lincolnshire

Send your letter to The Editor

Previous Topic (Agenda for Change)
Next Topic (The Society)

Back to Top


©The Pharmaceutical Journal